María Reyna Robles López

Dr. María Reyna Robles López

orcid

Research Focus & Metrics

Representative Publications

View All Publications
2 August 2025 in Viruses
Verified
Journal Article
Open access
PDF file
AGAlberto Margarito García-Munguía
Alberto Margarito García-Munguía
CMCARLOS ALBERTO GARCIA MUNGUIA
CARLOS ALBERTO GARCIA MUNGUIA
Paloma Guerra-ÁvilaPaloma Guerra-Ávila
Paloma Guerra-Ávila
EMEstefany Alejandra Sanchez Mendoza
Estefany Alejandra Sanchez Mendoza
Fabián Alejandro Rubalcava-CastilloFabián Alejandro Rubalcava-Castillo
Fabián Alejandro Rubalcava-Castillo
OGOtilio García-Munguía
Otilio García-Munguía
The use of chemical pesticides in agriculture has led to the development of resistant pest populations, posing a challenge to long-term pest management. This review aims to evaluate the scientific literature on the individual and combined use of baculoviruses with conventional chemical and biological insecticides to combat Plutella xylostella, Spodoptera exigua, and Spodoptera frugiperda in broccoli, tomato, and maize crops. Notable findings include that both individual Plutella xylostella nucleopolyhedrovirus (PxNPV) and the combination of Plutella xylostella granulovirus (PxGV) and azadirachtin at a low dose effectively control Plutella xylostella; both combinations of Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) with emamectin benzoate and chlorfenapyr reduced resistance in Spodoptera exigua and increased the efficacy of the insecticides; and the combination of Spodoptera frugiperda nucleopolyhedrovirus (SfMNPV) and spinetoram is effective against Spodoptera frugiperda. Integrating baculoviruses into pest management strategies offers a promising approach to mitigate the adverse effects of chemical pesticides, such as resistance development, health risks, and environmental damage. However, there remains a broad spectrum of research opportunities regarding the use of baculoviruses in agriculture.

30 June 2025 in Grasas y Aceites
Verified
Journal Article
Open access
PDF file
GSG.V. Salinas-Maldonado
G.V. Salinas-Maldonado
GCGabriel Cardoso-Ugarte
Gabriel Cardoso-Ugarte
Beatriz Pérez-ArmendárizBeatriz Pérez-Armendáriz
Beatriz Pérez-Armendáriz
MLMaría Reyna Robles López
María Reyna Robles López
MJMaría de Lourdes Meza Jiménez
María de Lourdes Meza Jiménez
Traditional extraction methods for vegetable oils present limitations regarding oil yield and quality preservation. Given the significant role of vegetable oils in human nutrition and health, non-thermal technologies offer alternatives for extraction process optimization. This review examines three principal non-thermal technologies: supercritical fluid extraction (SFE), ultrasound-assisted extraction (UAE), and pulsed electric field (PEF) application. These methods are evaluated based on their effects on extraction yield, oil composition, and the preservation of antioxidant activity in seed oils. SFE exhibits efficacy in enhancing yield, recovering antioxidant compounds, and preserving fatty acid compositions. UAE demonstrates potential for improving extraction efficiency and maintaining antioxidant activity. PEF consistently increases extraction yields, though its impacts on antioxidant properties and fatty acid profiles require additional investigation. These non-thermal technologies present viable alternatives for extraction process optimization, although further research is needed to maximize yield and quality across diverse oil seed varieties.

15 January 2026 in Translational Animal Science
Verified
Journal Article
Open access
CGCarlos A García-Munguía
Carlos A García-Munguía
MLMaría Reyna Robles López
María Reyna Robles López
DRDhamar A Ramírez-Castillo
Dhamar A Ramírez-Castillo
RRRaúl_René Robles_de-la-Torre
Raúl_René Robles_de-la-Torre
GGGloria P Galaviz-Martínez
Gloria P Galaviz-Martínez
AGAlberto M García-Munguía
Alberto M García-Munguía
Porcine reproductive and respiratory syndrome virus (PRRSV) represents a constant challenge for the swine industry, both in Mexico and internationally, due to its high genetic variability and immunosuppressive capacity. This study evaluated the comparative efficacy of four modified-live vaccines in 3 to 4-wk-old seronegative piglets challenged intramuscularly with the heterologous PRRSV strain DAP150520 at 35 d post-vaccination (dpv; 0 d post-challenge, dpc). Fifty piglets were randomly allocated into five groups (n = 10/group): G1, ATCC-VR-2332; G2, SJO151012 ≥ 104 (Porcimune); G3, P129; G4, attenuated Nebraska ≥ 4.0; and G5, unvaccinated controls. Outcomes included ELISA seroconversion, qRT-PCR cycle threshold (Ct) values (PRRSV RNA detection), daily clinical scoring, BW, and gross lung lesions assessed using the modified Madec scale at 7 dpc. Group 2 (Porcimune) showed complete seroconversion from 21 dpv, controlled post-challenge viremia (cycle threshold [Ct] = 21.84 at 7 dpc), and a 57% reduction in lung lesions compared with controls. Group 1 (ATCC-VR-2332) also reached complete seroconversion by 21 dpv, whereas Group 3 (P129) showed early but fluctuating seroconversion and Group 4 (attenuated Nebraska) showed delayed and inconsistent seroconversion across sampling points, and Group 5 (control) remained seronegative until after challenge. Group 3 achieved a 63% reduction in lung damage, although with a more variable immune response. In contrast, G1, G4, and the control group showed lung lesions in 100% of animals after challenge. Post-challenge BW gain was significantly greater in G1 and G2 than in the unvaccinated control (one-way ANOVA, P = 0.023; Tukey’s HSD, P = 0.039 and P = 0.045, respectively), meanwhile the control group showed a net BW loss after challenge. Overall, under these experimental conditions, Porcimune PRRS MLV was the only vaccine that differed significantly from unvaccinated controls in lung lesions, post-challenge BW gain and ELISA S/P ratio, supporting its protective potential against a heterologous PRRSV challenge.

5 November 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
CGCarlos A. García-Munguía
Carlos A. García-Munguía
OGOtilio García-Munguía
Otilio García-Munguía
Muyideen Olaitan BamideleMuyideen Olaitan Bamidele
Muyideen Olaitan Bamidele
María L. Flores-LópezMaría L. Flores-López
María L. Flores-López
LCLuis F. Cisneros-Guzmán
Luis F. Cisneros-Guzmán
AMArgelia García Munguía
Argelia García Munguía
Porcine reproductive and respiratory syndrome virus (PRRSV) remains one of the most economically significant pathogens of global swine production, and its genetic variability limits the field effectiveness of commercially licensed vaccines. Autogenous vaccines prepared from isolates recovered within a defined epidemiological unit are used at scale as a herd-specific alternative. This review distinguishes authorized autogenous products from experimental herd-specific preparations and from precision-vaccinology platforms that are neither authorized nor, given current development timelines, compatible with the autogenous use case. Following a structured search, the primary evidence base for efficacy is synthesized and found to comprise three studies from two research groups, including a single randomized controlled field trial. That evidence supports reductions in viraemia and lung pathology after homologous challenge, but not heterologous protection, and no study reports reproductive outcomes. The regulatory frameworks of the European Union, the United States and Mexico are compared, and are shown to authorize these products without requiring a demonstration of efficacy. Inactivation validation criteria, safety, breeding animals, interference with surveillance, isolate selection, where multiple variants co-circulate, and the absence of published economic evaluation are examined, together with the Latin American context, for which no field experience has been published.